2000
DOI: 10.1097/00000658-200009000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Endpoints of Resuscitation of Critically Injured Patients: Normal or Supranormal?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
99
1
4

Year Published

2003
2003
2013
2013

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 192 publications
(105 citation statements)
references
References 22 publications
1
99
1
4
Order By: Relevance
“…Supporters of early aggressive resuscitation in acute bleeding thought that the need to improve perfusion of vital organs was more important than any risk of aggravating hemorrhage. 39 Patients in severe hemorrhagic shock benefit from the use of intravenous crystalloids and colloids along with blood products. 40 In patients whose hemorrhage can not be controlled, infusion of large volumes of fluid results in increased blood loss.…”
Section: Discussionmentioning
confidence: 99%
“…Supporters of early aggressive resuscitation in acute bleeding thought that the need to improve perfusion of vital organs was more important than any risk of aggravating hemorrhage. 39 Patients in severe hemorrhagic shock benefit from the use of intravenous crystalloids and colloids along with blood products. 40 In patients whose hemorrhage can not be controlled, infusion of large volumes of fluid results in increased blood loss.…”
Section: Discussionmentioning
confidence: 99%
“…Compensatory mechanisms for progressive euvolemic anemia include not only an increase in cardiac output (increased left ventricular emptying and tachycardia) but also a change in the oxygen extraction ratio from the erythrocyte itself. Prospective randomized trials [42][43][44] and an additional meta-analyses [38][39][40][41][42][43][44] have failed to confirm the benefit of achieving supranormal values of oxygen delivery and oxygen use. They have also raised the possibility that this strategy may result in worse clinical outcomes and increased mortality.…”
Section: Oxygen Transportmentioning
confidence: 99%
“…Study or Subgroup Bishop, 1995Boldt, 1998Chytra, 2007Fleming, 1992Lobo, 2000Lobo, 2006Lopes, 2007Shoemaker, 1988Shultz, 1985 Total (95% CI) Total events Heterogeneity: Chi² = 3.01, df = 6 (P = 0.81); I² = 0% Test for overall effect: Z = 4.92 (P < 0.00001) Bender, 1997Berlauk, 1991Bishop, 1995Boldt, 1998Bonazzi, 2002Boyd, 1993Fleming, 1992Lobo, 2000Lobo, 2006Polonen, 2000Sandham, 2003Shoemaker, 1988Shultz, 1985Takala, 2000Ueno, 1998Valentine, 1997Velmahos, 2000Wilson, 1999 Ziegler, 1997…”
Section: Resultado: Disfunções Orgânicasmentioning
confidence: 99%
“…Bender, 1997 Berlauk, 1991Bishop, 1995Boldt, 1998Bonazzi, 2002Boyd, 1993Chytra, 2007Conway, 2002Donati, 2007Fleming, 1992Gan, 2002Kapoor, 2008Lobo, 2000Lobo, 2006Lopes, 2007Mythen, 1995Pearse, 2005Polonen, 2000Sandham, 2003Shoemaker, 1988Shultz, 1985Sinclair, 1997Stone, 2003Takala, 2000Ueno, 1998Valentine, 1997Velmahos, 2000Venn, 2002Wakeling, 2005Wilson, 1999 Ziegler, 1997…”
Section: Study or Subgroupmentioning
confidence: 99%
See 1 more Smart Citation